PEOPLE - British Biocell International makes appointment:
This article was originally published in Clinica
Alex Leyshon has been appointed as new business executive for British Biocell International (BBI). Mr Leyshon will be responsible for managing and developing customer accounts to aid the growth of core areas in the business, including: gold reagents; conjugation; and assay development. Cardiff, Wales-based BBI manufactures high-quality immunogold and silver reagents for research and diagnostic applications.